Acro Biomedical ACBM
OTC ACBM
$0.03 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Acro Biomedical (ACBM) Deferred Taxes (2018 - 2019)

Acro Biomedical (ACBM) posted Deferred Taxes of -$73071.0 for Q3 2019, little changed on a QoQ basis from -$73071.0 in Q2 2019.

Analysis

Acro Biomedical (ACBM) Deferred Taxes (2018 - 2019) Analysis & Trends

Acro Biomedical has reported Deferred Taxes for 2 years, with the latest figure at -$73071.0 in Q3 2019.

  • On a quarterly basis, Deferred Taxes changed N/A year-over-year to -$73071.0 in Q3 2019; TTM through Mar 2022 was -$73071.0, a 50.0% increase from a year earlier, with the FY2019 full-year figure at -$73071.0, changed N/A from the prior year.
  • Deferred Taxes was -$73071.0 for Q3 2019 at Acro Biomedical, roughly flat from -$73071.0 in the prior quarter.
  • The five-year high for Deferred Taxes was $45124.0 in Q1 2019, with the low at -$73071.0 in Q2 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Colgate Palmolive 70.27 Bn 68.90 Bn 3.30 Bn 3.00 Mn
2 Kenvue 34.17 Bn 33.06 Bn 2.30 Bn -10.00 Mn
3 Kimberly Clark 32.86 Bn 31.91 Bn 1.60 Bn -119.00 Mn
4 Bath & Body Works 3.85 Bn 3.05 Bn 692.00 Mn -
5 Prestige Consumer Healthcare 2.32 Bn 2.26 Bn - -
6 Perrigo 1.99 Bn 1.59 Bn 313.90 Mn -6.40 Mn
7 Herbalife 1.32 Bn 946.20 Mn 1.03 Bn -14.20 Mn
8 Edgewell Personal Care 1.24 Bn 842.99 Mn 242.50 Mn -600,000.00
9 TFA Therapeutics 1.02 Bn 1.02 Bn - -
10 Acro Biomedical 1.80 Mn 1.80 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 -73,071.00
Jun 30, 2019 -73,071.00
Mar 31, 2019 45,124.00
Dec 31, 2018 19,941.00